Our results suggests that molecular analysis correlates better with the MSI phenotype in the CRC, and the HSP110 (T17) improves the MSI determination in a routine setting of a Brazilian Cancer Hospital. This evidence concerns the gene HSPH1 and colorectal carcinoma.